Related Experiment Video
Updated: Jun 20, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Serogroup B meningococcal disease during Hajj: preparing for the worst scenario
Mohamed K M Khalil1, Ray Borrow
1Medical Research, Ministry of Health, Riyadh, Saudi Arabia. statkhl@hotmail.com
Abstract:
The Islamic Hajj pilgrimage to Mecca, Saudi Arabia has historically been associated with outbreaks of serogroup A and W135 meningococcal disease. Prevention against meningococcal disease has principally been vaccination with meningococcal polysaccharide vaccines, either in a bivalent serogroup A/C or quadrivalent A/C/Y/W135 form. These interventions have suppressed meningococcal disease since 2002. Countries with large Muslim populations have now started to show a trend of increased serogroup B meningococcal disease, a serogroup for which there is no universal vaccine available. These trends should increase our preparedness to expect a sudden change in the etiology of meningococcal disease during the Hajj.
Insights
Meningococcal disease outbreaks linked to the Hajj pilgrimage are shifting. Increased serogroup B cases, for which no universal vaccine exists, necessitate greater preparedness for future Hajj seasons.
Area of Science:
- Infectious disease epidemiology
- Vaccinology
- Public health surveillance
Background:
- The Islamic Hajj pilgrimage has historically seen outbreaks of meningococcal disease, particularly serogroups A and W135.
- Vaccination with meningococcal polysaccharide vaccines (bivalent A/C or quadrivalent A/C/Y/W135) has successfully suppressed these outbreaks since 2002.
Purpose of the Study:
- To highlight the emerging trend of serogroup B meningococcal disease in countries with large Muslim populations.
- To emphasize the need for increased preparedness for potential shifts in meningococcal disease etiology during the Hajj.
Main Methods:
- Observational analysis of historical meningococcal disease trends associated with the Hajj.
- Review of vaccination strategies and their impact on disease suppression.
- Monitoring of current serogroup trends in relevant populations.
Main Results:
- Meningococcal disease outbreaks primarily involving serogroups A and W135 have been historically associated with the Hajj.
- Vaccination efforts have significantly reduced the incidence of serogroups A and W135 meningococcal disease since 2002.
- A concerning trend of increased serogroup B meningococcal disease is now observed in populations undertaking the Hajj.
Conclusions:
- The shift towards serogroup B meningococcal disease poses a new challenge, as no universal vaccine is currently available.
- Enhanced surveillance and preparedness are crucial to manage the evolving threat of meningococcal disease during the Hajj pilgrimage.
- Future public health strategies must address the challenge of serogroup B in meningococcal disease prevention during mass gatherings.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Cryptococcal Meningitis
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Rocky Mountain Spotted Fever

